Vice President, Medical Affairs-Neuroscience

About the role

At Annexon Biosciences we are a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory diseases of the body, brain, and eye. Our novel scientific approach targets upstream C1q to block the classical complement inflammatory cascade before it starts, and its therapeutic candidates are designed to provide meaningful benefits across multiple autoimmune, neurodegenerative and ophthalmic diseases. With proof-of-concept data in Guillain‑Barré syndrome, Huntington’s disease and geographic atrophy, we are rigorously advancing our mid‑to‑late‑stage clinical trials to bring new potential treatments to patients as quickly as possible. At Annexon, you’ll be part of a team committed to making an impact together. We trade on Nasdaq under the ticker symbol ANNX and are headquartered in Brisbane, California, with preference given to candidates in the San Francisco Bay Area. The Vice President, Medical Affairs – Neuroscience will be responsible for representing Annexon Biosciences with a network of external thought leaders and driving Global Medical Affairs activities across complement-mediated neuroinflammatory and immunology-driven neurological diseases. This leader will play a critical role in advancing medical strategy in areas where immunology and neuroscience intersect, with a strong focus on diseases driven by dysregulation of the classical complement pathway.

Responsibilities

• As a key member of the neurology core team, provide deep medical and scientific expertise across neuroinflammatory disease biology and immunology-driven mechanisms, informing medical affairs, launch, and lifecycle strategies.
• Lead the full spectrum of the Medical Affairs functions that are responsible for the development and implementation of the Global medical strategy across the following areas:
  • Medical Affairs Operations – focused on communication, medical education, advisory management, and patient advocacy